ArticleCureus2026
Preoperative Gabapentin in Pediatric Anterior Cruciate Ligament Reconstruction With Peripheral Nerve Blockade: A Retrospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Preoperative gabapentin has been shown to reduce postoperative pain and opioid consumption following anterior cruciate ligament reconstruction (ACLR) in adult patients treated with local infiltration analgesia. Its effectiveness in pediatric patients receiving peripheral nerve blockade for ACLR remains unclear. Methods We conducted a retrospective, single-center cohort study of pediatric patients (<18 years) undergoing ACLR from 2019 to 2024. All patients received anterior sciatic and adductor canal peripheral nerve blocks. Patients were stratified by receipt of preoperative gabapentin. The primary outcome was total postoperative opioid usage prior to hospital discharge (morphine milligram equivalents, MME). Secondary outcomes included pain scores, sedation, block efficacy, and length of stay. Multivariable linear regression was performed adjusting for patient demographics, intraoperative opioid usage, anesthesiologist, and tourniquet time. Results A total of 79 patients were enrolled in the study, with 55 in the Gabapentin group and 24 in the No Gabapentin group. Postoperative opioid consumption was low and not significantly different between groups (Gabapentin 4.1 ± 9.2 vs No Gabapentin 5.2 ± 5.7 MME, p=0.08). In adjusted analysis, preoperative gabapentin was not associated with postoperative opioid use (β = -0.56, p=0.25). Pain scores, sedation, block efficacy, and length of stay were similar between groups. Intraoperative opioid use was significantly higher in the Gabapentin group (p<0.001). Nearly one-third of patients required no postoperative opioids prior to discharge. Conclusions Preoperative gabapentin was not associated with a detectable reduction in postoperative opioid use or improvement in pain control in pediatric ACLR patients receiving adductor canal and anterior sciatic peripheral nerve blocks. When highly effective regional anesthesia is employed, gabapentin may provide limited incremental benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.